-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ArriVent BioPharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q4 2024.
- ArriVent BioPharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 31.5M shares, a 1370% increase year-over-year.
- ArriVent BioPharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 31.5M shares, a 1370% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)